Dynamic Talk Life Sciences Session 1 - Developing an effective market access strategy to tackle growing pricing pressures in a challenging reimbursement environment
- After download go to: Resource Library
- Speakers: Giovanni Tafuri, Director International Market Access and Policy, Apellis Pharmaceuticals; Alan Crowther, General Manager, Global Pricing & Access Solutions, Eversana; Natasa Zibelnik, Global Head of Access, Value and Pricing, EUSA Pharma; Mercedes Prior, International Market Access Director, Grifols; MODERATOR: Elisabete Nunes Gonçalves, Assistant Director, HTA & Market Access, Real World and Late Phase, CTI Clinical Trial and Consulting Group
- Free Video: No
- VLT Viewable: Yes
- https://storage.googleapis.com/epp-content/dynamic%20talks/2022/Speakers%20BannerLI_DT_2022_17%20May.jpg
- https://storage.googleapis.com/epp-content/dynamic%20talks/2022/LS%20DT%2017%20May%202022.mp4
During these Dynamic Talks, 4 top experts will bring Visionary Talk sessions (3×20’) bringing answers to relevant discussions that are going on ;
- From greater adoption of Real-World Evidence to Joint EU HTA and increased cross-border collaboration – what’s the impact of new Market Access and Pricing trends in Europe in a post-pandemic economy?
- Pricing and Market Access launch excellence: identifying key drivers and challenges for a successful launch in a climate of change
- Assessing the side effects of greater Net Price Transparency for innovative medicines in Europe – adverse pricing consequences or perceived price fairness?
Open / In Class, 2020, Recorded Dynamic Talks
- Hits: 1041